Appen – Earnings Review

Posted on | by Leon Hinde

Machine learning and AI specialist Appen (APX) has downgraded its earnings guidance due to the COVID-19 pandemic downturn.

The company’s guidance is for EBITDA in the range of $100 million to $110 and the company anticipates a return to strong growth in FY22.

VanEck Global Healthcare Leaders ETF

Posted on | by Leon Hinde

VanEck Vectors Global Health Leaders is under Algo Engine buy conditions.

HLTH invests in a diversified portfolio of leading international developed markets (ex-Australia) companies with the best growth at a reasonable price (GARP) attributes from the global healthcare sector with the aim of providing investment returns, before fees and other costs, which track the
performance of the Index.

iShares Asia 50 ETF – Buy

Posted on | by Leon Hinde

iShares Asia 50 is under Algo Engine buy conditions and is a current holding in our iShares ETF model.

INVESTMENT OBJECTIVE: The fund aims to provide investors with the performance of the S&P Asia 50TM Index, before fees and expenses. The index is designed to measure the performance of the 50 leading companies listed in China, Hong Kong, Macau, Singapore, South Korea and Taiwan.

Wesfarmers – Buy

Posted on | by Leon Hinde

Wesfarmers is under Algo Engine buy conditions and is a current holding in our model portfolio.

Wesfarmers now holds 19.3% of Australian Pharmaceutical Industries. The acquisition has less than two weeks left in confirmatory due diligence. The battle between Sigma and Wesfarmers for the API business and final offers will be worth watching.

Accumulate WES within the $50 – $56 price range.

.